SYMBION has announced the
launch of a new division, Clinect, a
product management solution that
assists in bringing medicines currently
only available internationally into
Australia and NZ.
“Due to the relatively small
populations of Australia and NZ
there are many medicines which
can legally be prescribed by
specialists here but are just not
available to patients without going
through a complex and often
expensive importation process,”
said Stuart Spencer, GM of Group
Business Development at Symbion.The above article was sent to subscribers in Pharmacy Daily's issue from 22 Nov 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Nov 11
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.